Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |